Lista de obras - Gabriella Misso - Dominio Público Uruguay

A miRNA signature suggestive of nodal metastases from laryngeal carcinoma

artículo científico publicado en 2017

Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells

artículo científico publicado en 2015

Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients.

artículo científico publicado en 2017

Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action.

scientific article published on 28 March 2017

Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics

artículo científico publicado en 2022

Bisphosphonates and cancer: what opportunities from nanotechnology?

artículo científico publicado en 2013

Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports

artículo científico publicado en 2016

Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity

artículo científico publicado en 2011

Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC).

artículo científico publicado en 2010

Emerging pathways as individualized therapeutic target of multiple myeloma.

artículo científico

Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.

artículo científico publicado en 2009

Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid

artículo científico publicado en 2012

Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment.

artículo científico publicado en 2017

Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer

artículo científico publicado en 2019

Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery

artículo científico publicado en 2016

Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized

artículo científico publicado en 2014

Gene interference strategies as a new tool for the treatment of prostate cancer

artículo científico

Hepatocarcinoma: genetic and epigenetic features

artículo científico publicado en 2017

High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy

artículo científico publicado en 2014

Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients.

artículo científico publicado en 2016

Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients.

artículo científico publicado en 2012

Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey

artículo científico publicado en 2014

In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma

artículo científico publicado en 2014

Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies

artículo científico publicado en 2013

Lipid Nanoparticles to Deliver miRNA in Cancer.

artículo científico publicado en 2016

Measurement of Autophagy by Flow Cytometry.

artículo científico publicado en 2017

Mir-34: a new weapon against cancer?

artículo científico

Molecular targets for the treatment of multiple myeloma.

artículo científico

Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis).

artículo científico publicado en 2013

Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses

artículo científico publicado en 2016

Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment.

artículo científico publicado en 2016

Non-coding RNAs as a new dawn in tumor diagnosis.

artículo científico publicado en 2017

Optimal Management of Prostate Cancer Based on its Natural Clinical History.

artículo científico publicado en 2017

Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC.

artículo científico publicado en 2013

Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients

artículo científico publicado en 2011

Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water.

artículo científico publicado en 2008

Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev).

artículo científico publicado en 2017

Role of perineural invasion as a prognostic factor in laryngeal cancer

artículo científico publicado en 2016

Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.

artículo científico publicado en 2016

Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines.

artículo científico publicado en 2017

The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response.

artículo científico publicado en 2016

Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.

artículo científico publicado en 2016

Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma.

artículo científico publicado en 2014

Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse

artículo científico publicado en 2016

Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.

artículo científico publicado en 2016

W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac.

artículo científico publicado en 2009

Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells

artículo científico publicado en 2014

miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma

artículo científico publicado en 2019

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1

artículo científico publicado en 2012

Lista de obras de Gabriella Misso

A miRNA signature suggestive of nodal metastases from laryngeal carcinoma

Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells

Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients.

Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action.

Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics

Bisphosphonates and cancer: what opportunities from nanotechnology?

Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports

Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity

Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC).

Emerging pathways as individualized therapeutic target of multiple myeloma.

Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.

Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid

Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment.

Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer

Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery

Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized

Gene interference strategies as a new tool for the treatment of prostate cancer

Hepatocarcinoma: genetic and epigenetic features

High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy

Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients.

Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients.

Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey

In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma

Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies

Lipid Nanoparticles to Deliver miRNA in Cancer.

Measurement of Autophagy by Flow Cytometry.

Mir-34: a new weapon against cancer?

Molecular targets for the treatment of multiple myeloma.

Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis).

Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses

Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment.

Non-coding RNAs as a new dawn in tumor diagnosis.

Optimal Management of Prostate Cancer Based on its Natural Clinical History.

Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC.

Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients

Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water.

Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev).

Role of perineural invasion as a prognostic factor in laryngeal cancer

Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.

Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines.

The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response.

Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.

Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma.

Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse

Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.

W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac.

Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells

miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1